Skip to main content
Top
Published in: Clinical & Experimental Metastasis 2/2011

01-02-2011 | Research Paper

Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by hypoxia-inducible factor-1α

Authors: Florian Schelter, Birgit Halbgewachs, Petra Bäumler, Caroline Neu, Agnes Görlach, Florian Schrötzlmair, Achim Krüger

Published in: Clinical & Experimental Metastasis | Issue 2/2011

Login to get access

Abstract

The “protease web”, representing the network of proteases, their inhibitors, and effector molecules, arises as a pivotal determinant of tissue homeostasis. Imbalances of this network, for instance caused by elevated host levels of tissue inhibitor of metalloproteinases-1 (TIMP-1), have been shown to increase the susceptibility of target organs to scattered metastasis by inducing the hepatocyte growth factor (HGF) pathway. Increased expression of the hypoxia-inducible factor-1α-subunit (HIF-1α) is also associated with tumour progression and is also known to induce HGF-signaling via up-regulation of the HGF-receptor Met, namely under canonical stress conditions like lack of oxygen. Here, we aimed to identify a possible metastasis-promoting connection between TIMP-1, HIF-1α, and HGF-signaling. We found that HIF-1α and HIF-1-signaling were increased during liver metastasis of L-CI.5s T-lymphoma cells in TIMP-1 overexpressing syngeneic DBA/2 mice. In vitro, exposure of L-CI.5s cells to recombinant TIMP-1 revealed that TIMP-1 itself was able to induce HIF-1α and HIF-1-signaling. Knock-down of HIF-1α identified tumour cell-derived HIF-1α as mediator of this TIMP-1-induced invasiveness in vitro. In vivo, HIF-1α knock-down significantly impaired Met expression as well as Met phosphorylation and inhibited scattered liver metastasis. Furthermore, HGF-dependent TIMP-1-promoted Met phosphorylation and HGF-dependent TIMP-1-induced invasiveness in vitro was mediated by HIF-1α. We conclude that elevated levels of TIMP-1 in the microenvironment of tumour cells can promote metastasis by inducing HIF-1α-dependent HGF-signaling. This connection between a protease inhibitor (TIMP-1) and a classically stress-related factor (HIF-1α) is a so far undiscovered impact of the “protease web” on tissue homeostasis with important implications for metastasis.
Literature
1.
go back to reference Kaplan RN, Rafii S, Lyden D (2006) Preparing the “soil”: the premetastatic niche. Cancer Res 66(23):11089–11093CrossRefPubMed Kaplan RN, Rafii S, Lyden D (2006) Preparing the “soil”: the premetastatic niche. Cancer Res 66(23):11089–11093CrossRefPubMed
2.
go back to reference Overall CM, Dean RA (2006) Degradomics: systems biology of the protease web. Pleiotropic roles of MMPs in cancer. Cancer Metastasis Rev 25(1):69–75CrossRefPubMed Overall CM, Dean RA (2006) Degradomics: systems biology of the protease web. Pleiotropic roles of MMPs in cancer. Cancer Metastasis Rev 25(1):69–75CrossRefPubMed
3.
go back to reference Kopitz C et al (2007) Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling. Cancer Res 67(18):8615–8623CrossRefPubMed Kopitz C et al (2007) Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling. Cancer Res 67(18):8615–8623CrossRefPubMed
4.
go back to reference Schrotzlmair F et al. (2009) Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by host-derived urokinase-type plasminogen activator. J Cell Mol Med. doi:10.1111/j.1582-4934.2009.00951.x. Accessed 23 Oct 2009 Schrotzlmair F et al. (2009) Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by host-derived urokinase-type plasminogen activator. J Cell Mol Med. doi:10.​1111/​j.​1582-4934.​2009.​00951.​x. Accessed 23 Oct 2009
5.
go back to reference Benvenuti S, Comoglio PM (2007) The MET receptor tyrosine kinase in invasion and metastasis. J Cell Physiol 213(2):316–325CrossRefPubMed Benvenuti S, Comoglio PM (2007) The MET receptor tyrosine kinase in invasion and metastasis. J Cell Physiol 213(2):316–325CrossRefPubMed
6.
go back to reference Pennacchietti S et al (2003) Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3(4):347–361CrossRefPubMed Pennacchietti S et al (2003) Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3(4):347–361CrossRefPubMed
7.
go back to reference Mendoza M, Khanna C (2009) Revisiting the seed and soil in cancer metastasis. Int J Biochem Cell Biol 41(7):1452–1462CrossRefPubMed Mendoza M, Khanna C (2009) Revisiting the seed and soil in cancer metastasis. Int J Biochem Cell Biol 41(7):1452–1462CrossRefPubMed
8.
go back to reference Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4(11):891–899CrossRefPubMed Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4(11):891–899CrossRefPubMed
9.
go back to reference Pouyssegur J, Dayan F, Mazure NM (2006) Hypoxia signaling in cancer and approaches to enforce tumour regression. Nature 441(7092):437–443CrossRefPubMed Pouyssegur J, Dayan F, Mazure NM (2006) Hypoxia signaling in cancer and approaches to enforce tumour regression. Nature 441(7092):437–443CrossRefPubMed
10.
go back to reference Chan DA, Giaccia AJ (2007) Hypoxia, gene expression, and metastasis. Cancer Metastasis Rev 26(2):333–339CrossRefPubMed Chan DA, Giaccia AJ (2007) Hypoxia, gene expression, and metastasis. Cancer Metastasis Rev 26(2):333–339CrossRefPubMed
12.
go back to reference Wykoff CC et al (2000) Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60(24):7075–7083PubMed Wykoff CC et al (2000) Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60(24):7075–7083PubMed
13.
go back to reference Aiello L et al (1979) Adenovirus 5 DNA sequences present and RNA sequences transcribed in transformed human embryo kidney cells (HEK-Ad-5 or 293). Virology 94(2):460–469CrossRefPubMed Aiello L et al (1979) Adenovirus 5 DNA sequences present and RNA sequences transcribed in transformed human embryo kidney cells (HEK-Ad-5 or 293). Virology 94(2):460–469CrossRefPubMed
14.
go back to reference Krüger A, Schirrmacher V, von Hoegen P (1994) Scattered micrometastases visualized at the single-cell level: detection and re-isolation of lacZ-labeled metastasized lymphoma cells. Int J Cancer 58(2):275–284CrossRefPubMed Krüger A, Schirrmacher V, von Hoegen P (1994) Scattered micrometastases visualized at the single-cell level: detection and re-isolation of lacZ-labeled metastasized lymphoma cells. Int J Cancer 58(2):275–284CrossRefPubMed
15.
go back to reference Gerg M et al (2008) Distinct functionality of tumor cell-derived gelatinases during formation of liver metastases. Mol Cancer Res 6(3):341–351CrossRefPubMed Gerg M et al (2008) Distinct functionality of tumor cell-derived gelatinases during formation of liver metastases. Mol Cancer Res 6(3):341–351CrossRefPubMed
16.
go back to reference Jones N, Shenk T (1978) Isolation of deletion and substitution mutants of adenovirus type 5. Cell 13(1):181–188CrossRefPubMed Jones N, Shenk T (1978) Isolation of deletion and substitution mutants of adenovirus type 5. Cell 13(1):181–188CrossRefPubMed
17.
go back to reference Hitt M et al (1995) Techniques for human adenovirus vector construction and characterization. In: Adolph KW (ed) Viral gene techniques. Academic Press, San Diego, pp 13–30CrossRef Hitt M et al (1995) Techniques for human adenovirus vector construction and characterization. In: Adolph KW (ed) Viral gene techniques. Academic Press, San Diego, pp 13–30CrossRef
18.
go back to reference Arlt M et al (2002) Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-Cell lymphoma model. Cancer Res 62(19):5543–5550PubMed Arlt M et al (2002) Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-Cell lymphoma model. Cancer Res 62(19):5543–5550PubMed
19.
go back to reference Kopitz C et al (2005) Reduction of experimental human fibrosarcoma lung metastasis in mice by adenovirus-mediated cystatin C overexpression in the host. Cancer Res 65(19):8608–8612CrossRefPubMed Kopitz C et al (2005) Reduction of experimental human fibrosarcoma lung metastasis in mice by adenovirus-mediated cystatin C overexpression in the host. Cancer Res 65(19):8608–8612CrossRefPubMed
20.
go back to reference Kopitz C et al (2008) Plasminogen activator inhibitor-2, but not cystatin C, inhibits the prometastatic activity of tissue inhibitor of metalloproteinases-1 in the liver. Hum Gene Ther 19(10):1039–1049CrossRefPubMed Kopitz C et al (2008) Plasminogen activator inhibitor-2, but not cystatin C, inhibits the prometastatic activity of tissue inhibitor of metalloproteinases-1 in the liver. Hum Gene Ther 19(10):1039–1049CrossRefPubMed
21.
go back to reference Flannelly J et al (2002) Metalloproteinase and tissue inhibitor of metalloproteinase expression in the murine STR/ort model of osteoarthritis. Osteoarthr Cartil 10(9):722–733CrossRefPubMed Flannelly J et al (2002) Metalloproteinase and tissue inhibitor of metalloproteinase expression in the murine STR/ort model of osteoarthritis. Osteoarthr Cartil 10(9):722–733CrossRefPubMed
22.
go back to reference Joyce JA, Pollard JW (2009) Microenvironmental regulation of metastasis. Nat Rev Cancer 9(4):239–252CrossRefPubMed Joyce JA, Pollard JW (2009) Microenvironmental regulation of metastasis. Nat Rev Cancer 9(4):239–252CrossRefPubMed
23.
go back to reference Schelter F et al. (2010) Identification of a survival-independent metastasis-enhancing role of hypoxia-inducible factor-1{alpha} with a hypoxia-tolerant tumor cell line. J Biol Chem. doi: 10.1074/jbc.M110.140608 Schelter F et al. (2010) Identification of a survival-independent metastasis-enhancing role of hypoxia-inducible factor-1{alpha} with a hypoxia-tolerant tumor cell line. J Biol Chem. doi: 10.​1074/​jbc.​M110.​140608
Metadata
Title
Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by hypoxia-inducible factor-1α
Authors
Florian Schelter
Birgit Halbgewachs
Petra Bäumler
Caroline Neu
Agnes Görlach
Florian Schrötzlmair
Achim Krüger
Publication date
01-02-2011
Publisher
Springer Netherlands
Published in
Clinical & Experimental Metastasis / Issue 2/2011
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-010-9360-x

Other articles of this Issue 2/2011

Clinical & Experimental Metastasis 2/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine